You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Melanoma and at Least One Prior Systemic Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab, Sinoporphyrin Sodium, Photodynamic therapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital & Institute
Nov 23, 2022

Chronic GVHD Trial (Belumosudil)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • (no location specified)
Jan 5, 2023

Melanoma Trial in Charlottesville (Excision of clinically detected lymph node metastasis before any systemic therapy, Excision

Not yet recruiting
  • Melanoma
  • Excision of clinically detected lymph node metastasis before any systemic therapy
  • Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
  • Charlottesville, Virginia
    Cancer Center at the University of Virginia
Apr 20, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Cholangiocarcinoma Trial in Shanghai (Pemigatinib)

Active, not recruiting
  • Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Oct 3, 2022

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Triple Negative Breast Cancer Trial in United States (Trilaciclib, Sacituzumab Govitecan-hziy)

Recruiting
  • Triple Negative Breast Cancer
  • Chandler, Arizona
  • +21 more
Oct 25, 2022

Kyprolis® in Combination With Revlimid® and Dexamethasone or

Recruiting
  • Multiple Myeloma in Relapse
  • Frankfurt, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Jun 2, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Ewing's Sarcoma, Primitive Neuroectodermal Tumor (PNET), Askin's Tumor of the Chest Wall Trial in France, Italy, United States

Completed
Has Results
  • Ewing's Sarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Sep 30, 2021

Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in

Recruiting
  • Lung Cancer
    • Paris Cedex 5, France
      Local Institution
    Aug 31, 2021

    Unresectable or Metastatic Bone and Soft Tissue Sarcoma Trial (Mitoxantrone Hydrochloride Liposome Injection)

    Not yet recruiting
    • Unresectable or Metastatic Bone and Soft Tissue Sarcoma
    • Mitoxantrone Hydrochloride Liposome Injection
    • (no location specified)
    May 20, 2021

    Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)

    Active, not recruiting
    • Primary Non-metastatic Breast Cancer
    • Who Remain Disease-free
    • Lyon, France
    • +1 more
    Feb 23, 2022

    Metastatic Melanoma Trial in Orange (Disulfiram, Arsenic trioxide)

    Terminated
    • Metastatic Melanoma
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Aug 5, 2019

    Triple Negative Breast Cancer Trial (Camrelizumab?Capecitabine/eribulin/gemcitabine/vinorelbine,

    Not yet recruiting
    • Triple Negative Breast Cancer
    • (no location specified)
    Nov 22, 2021

    Advanced or Metastatic Colorectal Cancer (mCRC) Trial (CA102N)

    Available
    • Advanced or Metastatic Colorectal Cancer (mCRC)
    • (no location specified)
    Mar 2, 2022

    Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer Trial in United States (VERU-111,

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Androgen Resistant Prostatic Cancer
    • Anchorage, Alaska
    • +43 more
    Jan 3, 2023

    Endometrial Carcinoma, Cervix Carcinoma Trial in France (NP137, Pembrolizumab, Paclitaxel)

    Recruiting
    • Endometrial Carcinoma
    • Cervix Carcinoma
    • Bordeaux, France
    • +11 more
    Jun 7, 2022

    Chronic Graft-versus-host-disease Trial in United States (Belumosudil (KD025))

    Recruiting
    • Chronic Graft-versus-host-disease
    • Belumosudil (KD025)
    • Birmingham, Alabama
    • +35 more
    Sep 18, 2022

    NSCLC Trial in Worldwide (Nivolumab)

    Completed
    Has Results
    • Non-Small Cell Lung Cancer
    • Nivolumab
    • Birmingham, Alabama
    • +16 more
    Dec 1, 2022

    NSCLC Trial in Worldwide (Nivolumab)

    Completed
    Has Results
    • Non-Small Cell Lung Cancer
    • Wels, Oberösterreich, Austria
    • +89 more
    Oct 17, 2022

    AL Amyloidosis Trial in Worldwide (Melphalan-Flufenamide (Melflufen), Dexamethasone)

    Terminated
    • AL Amyloidosis
    • Boston, Massachusetts
    • +8 more
    Mar 10, 2022

    Solid Tumors, Adult Trial in Grand Rapids, Greenville, Dallas (ON123300)

    Recruiting
    • Solid Tumors, Adult
    • Grand Rapids, Michigan
    • +2 more
    Jan 27, 2022